URMC

PhotoPharmics Launches Largest Phototherapy Trial for Parkinson’s Disease

Retrieved on: 
Tuesday, March 26, 2024
Biotechnology, Neurology, Medical Devices, Health, Clinical Trials, PDQ, Depression, Parkinson's disease, Disease, Sleep, Patient, URMC, Research, Anxiety, University, Telehealth, Hope, Quality of life, Eye, Chet, Light, Clinical trial, Retina, Cognition, MDS, Tremor, Fatigue, FDA, The, Pharmaceutical industry

The "Celeste Light for PD Trial" (found at lightforpd.com) represents a significant stride in Parkinson’s disease (PD) treatment, leveraging innovative Spectramax™ technology through the passive and non-invasive Celeste® phototherapy device.

Key Points: 
  • The "Celeste Light for PD Trial" (found at lightforpd.com) represents a significant stride in Parkinson’s disease (PD) treatment, leveraging innovative Spectramax™ technology through the passive and non-invasive Celeste® phototherapy device.
  • This pivotal trial will assess the efficacy of Celeste®, the company’s FDA Breakthrough phototherapy device to improve non-motor and motor function and quality of life in Parkinson’s disease (PD).
  • This 300-patient phototherapy trial will be the largest trial of its kind.
  • “A pivotal trial for medical devices is similar to a phase 3 trial drug trial,” said Dan Adams, chief science officer.

URMC Announces First-of-its-Kind Alliance to Expand Health Care Access to Rural Communities

Retrieved on: 
Tuesday, February 6, 2024
Other Science, Technology, Research, Managed Care, General Health, Telemedicine, Virtual Medicine, Social Services, Health Technology, Hospitals, Finance, Banking, Professional Services, Other Technology, Other Education, Telecommunications, University, Health, Networks, Education, Science, Internet, Digital health, Telehealth, Star Bank, Greater, Obesity, Verizon Business, Patient, Five Star Bank, FWA, Finger Lakes, Central New York, Organization, URMC, Financial institution, Poverty, Risk, Type 2 diabetes, Roflumilast, Stroke, Health care, Digital divide, Cancer, American Heart Association, Hospital

“This pilot is the next evolution, bringing telemedicine to those who may lack access to technology at home.

Key Points: 
  • “This pilot is the next evolution, bringing telemedicine to those who may lack access to technology at home.
  • “As a community bank serving much of Western and Central New York, we understand the unique challenges our rural communities face.
  • “A digital visit is a building block for patients to regain control of their wellness, and an opportunity for health systems to expand their footprint to deliver more care and services.”
    Americans living in rural regions experience significant health disparities, due in part to limited access to health care.
  • This pilot initiative will serve three rural communities – all with limited health care providers and where many residents lack broadband home internet.

CEO Todd Liebert Recognized as a 2022 ICON Honoree

Retrieved on: 
Friday, December 9, 2022
Constellation, American Institute, RRH, ROC, American Heart Association, CGR, Critical care, Center for Governmental Research, Humane society, St Ann's, URMC, CPL, Real estate, Hillside Family of Agencies, Rochester Regional Health, CPL Resources, University of Rochester Medical Center, GRE, Service, A/E, Executive sponsor, AHA, City, Genesee Hospital, Multimedia, CALD, University, Ageing, Culture, Transport, Higher education, Liebert, American Institute of Architects, Downtown Rochester, K–12, Workforce, Wayne Central School District, Greater, Senior living, Community, AIA, Architecture, FGI, Engineering, NCARB, Management, Medicine, Interior design, Health care

ROCHESTER, N.Y., Dec. 9, 2022 /PRNewswire/ -- CPL, a full-service design firm serving public and private-sector clients for more than 47 years, is pleased to congratulate Chief Executive Officer (CEO) Todd Liebert, AIA, NCARB on being named a 2022 ICON Honoree by the Rochester Business Journal (RBJ).

Key Points: 
  • ROCHESTER, N.Y., Dec. 9, 2022 /PRNewswire/ -- CPL, a full-service design firm serving public and private-sector clients for more than 47 years, is pleased to congratulate Chief Executive Officer (CEO) Todd Liebert, AIA, NCARB on being named a 2022 ICON Honoree by the Rochester Business Journal (RBJ).
  • Liebert formally received the ICON Honor Award at a celebratory event held at the Genesee Valley Club on December 5.
  • "Todd embodies the description of an ICON Honoree in every way," said CPL President, Rick Henry, P.E.
  • In his role as CEO, Liebert is responsible for setting financial parameters and aspirations for the firm's acquisitive growth and sustained success.

UNIVERSITY OF ROCHESTER MEDICAL CENTER SELECTS SECTRA ENTERPRISE IMAGING IN THE CLOUD

Retrieved on: 
Monday, October 17, 2022
Cloud, Physician, International, Caregiver, Ophthalmology, Cardiology, URMC, Architecture, Academic health science centre, Hospital, University of Rochester Medical Center, Microsoft, University, Education, Epic Systems, Health, Microsoft Azure, Azure, Elective surgery, VNA, Pathology, Medical imaging, Sectra AB

SHELTON, Conn., Oct. 17, 2022 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide enterprise imaging as a cloud subscription service (Sectra One Cloud), throughout the University of Rochester Medical Center (URMC).

Key Points: 
  • SHELTON, Conn., Oct. 17, 2022 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide enterprise imaging as a cloud subscription service (Sectra One Cloud), throughout the University of Rochester Medical Center (URMC).
  • This will allow the health system scalability as enterprise imaging volumes grow, in a secure and fully managed cloud environment.
  • The University of Rochester Medical Center is one of the nation's leading academic medical centers.
  • Sectra offers a complete enterprise solution comprised of imaging modules(radiology, cardiology,pathology, orthopedics, and ophthalmology), and a robust VNA.

AACC Elects New Leaders to Serve Terms Starting in August 2022

Retrieved on: 
Wednesday, June 15, 2022
ASCP, Pathology, St. Paul's Hospital, Science, University, University of Pittsburgh Medical Center, Leadership, University of Rochester Medical Center, Wilfrid Sellars, MD, Health, Hospital, University of North Carolina School of Law, NRCC, Association, Health equity, AACC, Child, Physician, FRCPC, University of Pittsburgh School of Medicine, Medical college, Medical College of Wisconsin, Doctor of Philosophy, URMC, Knowledge, UPMC, CPP, Mass spectrometry, Toxicology, Chapel Hill, University of California, San Diego, UPMC Children's Hospital of Pittsburgh, Paul the Apostle, MBA, CC, Committee, Point-of-care testing, Head, Awareness, Management, Medical device, Pharmaceutical industry

Following this, she will serve successive terms as the association's president from August 2023-July 2024 and as past president from August 2024-July 2025.

Key Points: 
  • Following this, she will serve successive terms as the association's president from August 2023-July 2024 and as past president from August 2024-July 2025.
  • They will take office in August 2022 along with the incoming president of AACC Academy and the incoming chair of the AACC Clinical Laboratory Scientists Council, both of whom will also serve on the board.
  • "I am elated that AACC's membership has elected me to serve as president-elect of the association," said Dr. Peck Palmer.
  • An AACC member since 2005, he currently serves on the AACC Education Core Committee and as past chair of the AACC Endocrinology Division.

Living Organ Donors Open New Doors for Colorectal Cancer Patients in Need of Liver Transplants

Retrieved on: 
Wednesday, March 30, 2022
Journal, Recurrence, American Medical Association, Liver, Colorectal cancer, Ottawa Hospital Research Institute, Survival, Research, URMC, Patient, Cancer, UHN, Quality of life, Cleveland Clinic, University, Cleveland, Transplant, Department, University Health Network, Dentistry, Pharmaceutical industry

A year and a half after their transplants, all 10 patients were alive and 62 percent remained cancer free.

Key Points: 
  • A year and a half after their transplants, all 10 patients were alive and 62 percent remained cancer free.
  • According to the study, a year and a half after their living-donor liver transplants, all 10 patients were alive and 62 percent remained cancer free.
  • , who is chief of the Abdominal Transplant and Liver Surgery Division at URMC , which has performed more living donor liver transplants for patients with colorectal liver metastases than any other center in North America.
  • Unfortunately, these patients are highly unlikely to receive a deceased-donor liver transplant due to chronic organ shortages in North America.

Spok Provides University of Rochester Medical Center with Spok Care Connect® to Enhance Operator Services and Improve Clinical Communication

Retrieved on: 
Wednesday, March 2, 2022
Mobile, Wireless, Technology, Security, Public Relations, Investor Relations, Communications, Telecommunications, Software, General Health, Health, Data Management, SPOK, Hospital, University of Rochester Medical Center, Directory, View, Publicis Healthcare Communications Group, Twitter, University, Solution, Strong Memorial Hospital, Communication, Messenger, URMC, NASDAQ, Medicine, Spok

We believe the Spok Care Connect platform provides a good match for all of our needs.

Key Points: 
  • We believe the Spok Care Connect platform provides a good match for all of our needs.
  • URMC will deploy Spok Smart Console for operator services and Spok Messenger for critical connectivity and to support fast clinical response.
  • Top hospitals rely on the Spok Care Connect platform to enhance workflows for clinicians and support administrative compliance.
  • Spok is a trademark of Spok Holdings, Inc. Spok Care Connect and Spok Mobile are trademarks of Spok, Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20220302006005/en/

Butterfly Network Introduces Butterfly Blueprint and World's First FDA-Cleared AI Guidance & Interpretation Software to Support the Practical Application of Ultrasound Information

Retrieved on: 
Monday, February 28, 2022
Health, FDA, Technology, Other Health, Software, General Health, Hardware, Blueprint, Center, Security (finance), COVID-19, NTAP, Butterfly network, University of Rochester Medical Center, Private Securities Litigation Reform Act, Â, Health, Partnership, Growth, HIMSS, U.S. Securities and Exchange Commission, PACS, Licensed practical nurse, Multimedia, CEO, New, Medicare, Patient-centered outcomes, Value, Auscultation, Efficiency, Diagnosis, United Kingdom, Patient, CMS, Network, Software, Apple, Exhibition, Mark (given name), University, URMC, Centers for Medicare & Medicaid Services, Android, NYSE, Tablet, Conference, Marketing, EMR, Technology, Caption, Hospital, Medical imaging, Butterfly

View the full release here: https://www.businesswire.com/news/home/20220228005235/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220228005235/en/
    Leveraging Butterflys unique combination of a whole-body handheld ultrasound device, software, and services, Blueprint brings hospitals and health systems a complete ultrasound solution.
  • By integrating into health systems clinical and administrative systems and workflows, Blueprint delivers a clinical assessment tool at scale.
  • Butterfly Blueprint is complemented with a rich set of optional software and services including Caption Healths AI-guided software.
  • By integrating Caption AI with Butterfly iQ+, were expanding diagnostic toolkits for hospitals, health systems, and wherever a patient needs care.

Concentric Analgesics Forges Important Phase 3 Clinical Relationships for Vocacapsaicin, a Non-Opioid Pain Therapy Targeting TRPV1 Receptor

Retrieved on: 
Wednesday, February 2, 2022
Health, Surgery, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, News, Safety, Patient, Rehabilitation, TKA, Sports medicine, Food, University, University of Rochester Medical Center, Scripps Research, Korea Disease Control and Prevention Agency, UCSF, Nobel Prize, TRPV1, Elective surgery, Death, Anesthetic, Doctor of Public Health, ERG, Center, Research, URMC, U.S. News & World Report, Medicine, Hospital, Ambulatory Surgery Center Association, Temperature, Capsaicin, Science, Prodrug, Target, Fast track (FDA), Pain, Outpatient surgery, Regulation of tobacco by the U.S. Food and Drug Administration, Nobel Prize in Physiology or Medicine, Therapy, Discovery (observation), Concentric objects, OTC, Mark (given name), Traffic, Pharmaceutical industry, Analgesic, Physiology

Concentric Analgesics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, non-opioid pain therapeutics, today announced two important Phase 3 clinical relationships for its lead product candidate, vocacapsaicin.

Key Points: 
  • Concentric Analgesics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, non-opioid pain therapeutics, today announced two important Phase 3 clinical relationships for its lead product candidate, vocacapsaicin.
  • URMC will participate in the vocacapsaicin Phase 3 clinical trials and develop innovative methods to capture vocacapsaicins benefit to patient recovery and rehabilitation.
  • Concentric Analgesics lead product candidate for postsurgical pain is a proprietary first-in-class prodrug therapeutic that rapidly converts to capsaicin, a potent TRPV1 agonist.
  • Concentric Analgesics is a clinical-stage, biopharmaceutical company focused on developing and commercializing novel, non-opioid pain therapeutics.

Loopback Analytics Working with the University of Rochester Medical Center on Specialty Pharmacy Initiatives to Improve Patient Outcomes

Retrieved on: 
Wednesday, January 19, 2022
Patient, Research, Dentistry, Education, Pharmacy, University of Rochester Medical Center, URMC, Health, Eastman Institute for Oral Health, Loopback, Academic health science centre, Hospital, University, Eastmaninstitutet, Strong Memorial Hospital, Medicine, Nursing

DALLAS, Jan. 19, 2022 /PRNewswire/ -- Loopback Analytics, a leading provider of data-driven solutions for hospitals and health systems, is excited to announce it is working with the University of Rochester Medical Center (URMC) to continue advancing specialty pharmacy services.

Key Points: 
  • DALLAS, Jan. 19, 2022 /PRNewswire/ -- Loopback Analytics, a leading provider of data-driven solutions for hospitals and health systems, is excited to announce it is working with the University of Rochester Medical Center (URMC) to continue advancing specialty pharmacy services.
  • "We are thrilled to be providing our pharmacy analytics platform to bolster URMC's efforts to improve patient care and advance their specialty pharmacy growth efforts," said Neil Smiley, Loopback Analytics CEO.
  • The University of Rochester Medical Center is a private, coeducational, nonsectarian, and nonprofit research university.
  • The medical center includes Strong Memorial Hospital, the Eastman Institute for Oral Health, the University of Rochester School of Medicine and Dentistry, with its faculty practice (University of Rochester Medical Faculty Group), and the University of Rochester School of Nursing.